Phone: 614/488-2118
Fax: 614/488-2647

1335 Dublin Rd., Suite 124A
Columbus, OH 43215

Protocol Categories

View All Protocols


CA Control

Alliance A011104
Effect of Preoperative Breast MRI on Surgical Outcomes,Costs and Quality of Life of Women with Breast Cancer
Alliance A221504
A Randomized, Double-Blind, Placebo-Controlled Pilot Study of an Oral, Selective Peripheral Opioid Receptor Antagonist in Advanced Non-Small Cell Lung Cancer (Adenocarcinoma)
Alliance A221505
Phase III Randomized Trial of Hypofractionated Post Mastectomy Radiation with Breast Reconstruction
Alliance A221701
Phase III Placebo-Controlled Trial to Evaluate Dexamethasone Use for Everolimus-Induced Oral Stomatitis: Prevention versus Early Treatment Approaches
ECOG E1Q11
EROS: Engendering Reproductive Health within Oncologic Survivorship
NCI DCP-001
Use of a Clinical Screening Tool to Address Cancer Health Disparities in the NCI Community Oncology Research Program (NCORP)
NRG CC004
Phase II Double Blind Dose Finding Trial of Bupropion Versus Placebo for Sexual Desire in Women With Breast or Gynecologic Cancer
OSU 2010-C0126 Buckeye Surveillance
Buckeye Surveillance, Contact, and Research for MGUS, Myeloma and Amyloidosis
SWOG S0820
"""A Double Blind Placebo-Controlled Trial of Eflornithine and Sulindac to Prevent Recurrence of High Risk Adenomas and Second Primary Colorectal Cancers in Patients with Stage 0-III Colon or Rectal Cancer,Phase III รป Preventing Adenomas of the Colon with Eflornithine and Sulindac(PACES)""."
URCC 16070
Treatment of Refractory Nausea
Wake Forest WF 10217 WAYS
Work Ability in Young Adult Survivors (WAYS)
Wake Forest WF 1801
A Single Arm, Pilot Study of Ramipril for Preventing Radiation-Induced Cognitive Decline in Glioblastoma (GBM) Patients Receiving Brain Radiotherapy
Wake Forest WF 1802
Influence of Primary Treatment for Prostate Cancer on Work Experience (PCW)
Wake Forest WF 97115
A Phase III Prospective Randomized Trial of Acupuncture forTreatment of Radiation-Induced Xerostomia in Patients with Head and Neck Cancer
Wake Forest WF 97116
A Phase 3 Randomized Placebo Controlled Clinical Trial of Donepezil in Chemotherapy Exposed Breast Cancer Survivors with Cognitive Impairment